Hysingla ER Medication Guide
Download important information about this medication.
Resources for patients and caregivers
Helpful programs and information
If your healthcare provider has prescribed Hysingla ER as part of your treatment plan, you will find valuable information in these resources:
- The Hysingla Medication Guide, which gives you important safety information about Hysingla ER View the Medication Guide
- The Hysingla Full Prescribing Information View the Full Prescribing Information
Risk Evaluation and Mitigation Strategy (REMS)
Hysingla ER is subject to the REMS for opioid analgesics
The goal of the REMS is to reduce serious adverse outcomes resulting from inappropriate prescribing, abuse, and misuse of opioid analgesics, while maintaining patient access to pain medications. Adverse outcomes of concern include addiction, unintentional overdose, and death.
- FDA has required a REMS for all opioid analgesics
- Purdue Pharma is a member of the REMS Program Companies
Hysingla ER should be prescribed only by healthcare professionals who are knowledgeable in the use of potent opioids for the management of chronic pain.
Documentation and maintenance of careful prescribing and treatment records are essential, and should include:
- Physician and patient agreement
- Proper assessment of the patient
- Proper prescribing practices
- Periodic reevaluation of therapy
- Proper dispensing and correct storage and handling
- Careful record keeping of prescribing information, including quantity, frequency, and renewal requests, is strongly advised
- Providing patient and/or caregiver with the Medication Guide
- Reviewing the Opioid REMS Patient Counseling Guide with the patient and/or caregiver at the time of prescribing
For more information, including REMS-compliant educational CME/CE programs on safe prescribing of REMS for opioid analgesics, visit opioidanalgesicrems.com.